Inventor · disambiguated record
Jin-Chen Yu
Also filed as: YU JIN · YU JIN-CHEN
7 granted patents·26 pending applications·34 citations·filing 2002–2023
81Inventor score
Files withBIO THERA SOLUTIONS LTD21BIO THERA SOLUTIONS LTD CO3CHEN RUIHONG3ONCOSYNERGY INC2ARENA PHARM INC1
Top patents by PatentIndex Score
33 records- 0188US8487004B2Local treatment of neurofibromasCHEN RUIHONG·Filed 2012·Granted Jul 16, 2013·14 cites·5 claims
- 0285US8211875B2Local treatment of neurofibromasCHEN RUIHONG·Filed 2006·Granted Jul 3, 2012·9 cites·2 claims
- 0380US11192954B2Compounds and methods for the treatment of TROP2 positive diseasesBIO THERA SOLUTIONS LTD·Filed 2018·Granted Dec 7, 2021·3 cites·18 claims
- 0471US8329683B2Treatment of neurofibromatosis with radicicol and its derivativesCHEN RUIHONG·Filed 2009·Granted Dec 11, 2012·2 cites·13 claims
- 0562US2025388667A1Anti-nectin-4 antibody and use thereofBIO THERA SOLUTIONS LTD·Filed 2023·Application pending·0 cites
- 0660US2025249114A1Method for treating her2-positive solid tumorBIO THERA SOLUTIONS LTD·Filed 2023·Application pending·0 cites
- 0759US6710075B2Therapeutic compounds and methodsGOVERNMENT OF THE STATE OF SAR·Filed 2002·Granted Mar 23, 2004·6 cites·34 claims
- 0859US2025333498A1Anti-cldn18.2 antibody, and antibody-drug conjugate and use thereofBIO THERA SOLUTIONS LTD·Filed 2023·Application pending·0 cites
- 0958US12371491B2Anti-TIGIT immunosuppressant and application thereofBIO THERA SOLUTIONS LTD·Filed 2020·Granted Jul 29, 2025·0 cites·16 claims
- 1058US2025262316A1Antibody-drug conjugate and application thereofBIO THERA SOLUTIONS LTD·Filed 2022·Application pending·0 cites
- 1158US2025381283A1Method for treating solid tumorBIO THERA SOLUTIONS LTD·Filed 2023·Application pending·0 cites
- 1258US2025051450A1Use of anti-pd-l1/cd47 bispecific antibody in treatment of diseasesBIO THERA SOLUTIONS LTD·Filed 2022·Application pending·0 cites
- 1356US2025059274A1ANTI-FRa ANTIBODY, AND ANTIBODY-DRUG CONJUGATE AND USE THEREOFBIO THERA SOLUTIONS LTD·Filed 2022·Application pending·0 cites
- 1456US2024269315A1Drug conjugate and use thereofBIO THERA SOLUTIONS LTD·Filed 2022·Application pending·0 cites
- 1555US2013345244A1Local treatment of neurofibromasNexgenix Pharmaceuticals Inc·Filed 2013·Application pending·0 cites
- 1654US2024400690A1Anti-b7-h3 antibody and application thereofBIO THERA SOLUTIONS LTD·Filed 2022·Application pending·0 cites
- 1752US2023287126A1Anti-pd-l1 antibody and use thereofBIO THERA SOLUTIONS LTD·Filed 2021·Application pending·0 cites
- 1852US2014135290A1Macrocyclic prodrug compounds useful as therapeuticsONCOSYNERGY INC·Filed 2013·Application pending·0 cites
- 1952US2023279144A1Anti-her2 antibody and use thereofBIO THERA SOLUTIONS LTD·Filed 2021·Application pending·0 cites
- 2051US2023416386A1Use of anti-ox40 antibody in treatment of tumor or cancerBIO THERA SOLUTIONS LTD·Filed 2021·Application pending·0 cites
- 2151US2024067728A1Bispecific antibody and use thereofBIO THERA SOLUTIONS LTD·Filed 2021·Application pending·0 cites
- 2251US2014178413A1Compounds and methods for the treatment of erb b2/neu positive diseasesBIO THERA SOLUTIONS LTD CO·Filed 2013·Application pending·0 cites
- 2351US2024092892A1Anti-cldn18.2 antibody, and preparation method therefor and use thereofBIO THERA SOLUTIONS LTD·Filed 2021·Application pending·0 cites
- 2451US2023303711A1Anti-cd47 antibody and use thereofBIO THERA SOLUTIONS LTD·Filed 2021·Application pending·0 cites
- 2550US2023203164A1Anti-ctla-4 monoclonal antibody, preparation method therefor, and application thereofBIO THERA SOLUTIONS LTD·Filed 2020·Application pending·0 cites
- 2649US2017258935A1Compounds and methods for the treatment of erb b2/neu positive diseasesBIO-THERA SOLUTIONS LTD CO·Filed 2017·Application pending·0 cites
- 2748US9737616B2Compounds and methods for the treatment of ERB B2/NEU positive diseasesBIO-THERA SOLUTIONS LTD CO·Filed 2015·Granted Aug 22, 2017·0 cites·2 claims
- 2848US2022409580A1Methods of treating conditions related to the s1p1 receptorARENA PHARM INC·Filed 2020·Application pending·0 cites
- 2948US2023139700A1Development and application of immune cell activatorBIO THERA SOLUTIONS LTD·Filed 2021·Application pending·0 cites
- 3047US2024002511A1Use of anti-pd-1 antibody in combination therapyBIO THERA SOLUTIONS LTD·Filed 2021·Application pending·0 cites
- 3146US2011190237A1Macrocyclic Prodrug Compounds Useful as TherapeuticsNEXGENIX PHARMACEUTICALS·Filed 2010·Application pending·0 cites
- 3246US2023338526A1Anti-cd20 antibody formulation and use of anti-cd20 antibody for treatment of cd20 positive diseasesBIO THERA SOLUTIONS LTD·Filed 2020·Application pending·0 cites
- 3345US2015182452A1Local treatment of neurofibromasONCOSYNERGY INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jin-Chen Yu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →